Literature DB >> 23335944

HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships.

Elaine L Bearer1.   

Abstract

HSV, a neurotropic virus, travels within neuronal processes by fast axonal transport. During neuronal infection HSV travels retrograde from the sensory nerve terminus to the neuronal cell body, where it replicates or enters latency. During replication HSV travels anterograde from the cell body to the nerve terminus. Postmortem studies find a high frequency of HSV DNA in the trigeminal ganglia as well as the brain. Studies correlating HSV with Alzheimer's disease (AD) have been controversial. Here we review clinical evidence supporting such a link. Furthermore, the author describes experimental data showing physical interactions between nascent HSV particles and host transport machinery implicated in AD. The author concludes that the complexity of this relationship has been insufficiently explored, although the relative ease and nontoxicity of a potential anti-HSV treatment for AD demands further study.

Entities:  

Year:  2012        PMID: 23335944      PMCID: PMC3546524          DOI: 10.2217/fvl.12.81

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  109 in total

1.  Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease.

Authors:  C E Saldanha; J Lubinski; C Martin; T Nagashunmugam; L Wang; H van Der Keyl; R Tal-Singer; H M Friedman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

3.  Herpes simplex virus type I induces the accumulation of intracellular β-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells.

Authors:  Soraya Santana; Maria Recuero; Maria Jesús Bullido; Fernando Valdivieso; Jesus Aldudo
Journal:  Neurobiol Aging       Date:  2011-01-26       Impact factor: 4.673

4.  Neuritic transport of herpes simplex virus in rat sensory neurons in vitro. Effects of substances interacting with microtubular function and axonal flow [nocodazole, taxol and erythro-9-3-(2-hydroxynonyl)adenine].

Authors:  K Kristensson; E Lycke; M Röyttä; B Svennerholm; A Vahlne
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

5.  Herpes simplex encephalitis: involvement of apolipoprotein E genotype.

Authors:  W R Lin; M A Wozniak; M M Esiri; P Klenerman; R F Itzhaki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

6.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Authors:  Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

7.  Oral acyclovir suppression and neurodevelopment after neonatal herpes.

Authors:  David W Kimberlin; Richard J Whitley; Wen Wan; Dwight A Powell; Gregory Storch; Amina Ahmed; April Palmer; Pablo J Sánchez; Richard F Jacobs; John S Bradley; Joan L Robinson; Mark Shelton; Penelope H Dennehy; Charles Leach; Mobeen Rathore; Nazha Abughali; Peter Wright; Lisa M Frenkel; Rebecca C Brady; Russell Van Dyke; Leonard B Weiner; Judith Guzman-Cottrill; Carol A McCarthy; Jill Griffin; Penelope Jester; Misty Parker; Fred D Lakeman; Huichien Kuo; Choo Hyung Lee; Gretchen A Cloud
Journal:  N Engl J Med       Date:  2011-10-06       Impact factor: 91.245

8.  Herpesviruses in brain and Alzheimer's disease.

Authors:  Woan-Ru Lin; Matthew A Wozniak; Robert J Cooper; Gordon K Wilcock; Ruth F Itzhaki
Journal:  J Pathol       Date:  2002-07       Impact factor: 7.996

Review 9.  Acyclovir: discovery, mechanism of action, and selectivity.

Authors:  G B Elion
Journal:  J Med Virol       Date:  1993       Impact factor: 2.327

10.  Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels.

Authors:  Catherine Féart; Catherine Helmer; Hervé Fleury; Yannick Béjot; Karen Ritchie; Philippe Amouyel; Susanna Schraen-Maschke; Luc Buée; Jean-Charles Lambert; Luc Letenneur; Jean-François Dartigues
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

View more
  20 in total

1.  Neuropathology of JC virus infection in progressive multifocal leukoencephalopathy in remission.

Authors:  Karen S SantaCruz; Gulmohor Roy; James Spigel; Elaine L Bearer
Journal:  World J Virol       Date:  2016-02-12

Review 2.  A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System.

Authors:  Anna Bellizzi; Nicholas Ahye; Gauthami Jalagadugula; Hassen S Wollebo
Journal:  J Neuroimmune Pharmacol       Date:  2019-09-11       Impact factor: 4.147

Review 3.  Inflammation in neurodegenerative diseases--an update.

Authors:  Sandra Amor; Laura A N Peferoen; Daphne Y S Vogel; Marjolein Breur; Paul van der Valk; David Baker; Johannes M van Noort
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 4.  Autophagy interaction with herpes simplex virus type-1 infection.

Authors:  Douglas O'Connell; Chengyu Liang
Journal:  Autophagy       Date:  2016-03-02       Impact factor: 16.016

Review 5.  Molecular network analysis enhances understanding of the biology of mental disorders.

Authors:  Kay S Grennan; Chao Chen; Elliot S Gershon; Chunyu Liu
Journal:  Bioessays       Date:  2014-04-14       Impact factor: 4.345

Review 6.  Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus.

Authors:  Ruth F Itzhaki
Journal:  Front Aging Neurosci       Date:  2014-08-11       Impact factor: 5.750

Review 7.  HSV-1 and Alzheimer's disease: more than a hypothesis.

Authors:  Roberto Piacentini; Giovanna De Chiara; Domenica D Li Puma; Cristian Ripoli; Maria E Marcocci; Enrico Garaci; Anna T Palamara; Claudio Grassi
Journal:  Front Pharmacol       Date:  2014-05-07       Impact factor: 5.810

8.  Antiviral treatment associated with reduced risk of clinical Alzheimer's disease-A nested case-control study.

Authors:  Eva-Stina Hemmingsson; Ellen Hjelmare; Bodil Weidung; Jan Olsson; Maria Josefsson; Rolf Adolfsson; Lars Nyberg; Fredrik Elgh; Hugo Lövheim
Journal:  Alzheimers Dement (N Y)       Date:  2021-06-09

9.  In vivo axonal transport deficits in a mouse model of fronto-temporal dementia.

Authors:  Tabassum Majid; Yousuf O Ali; Deepa V Venkitaramani; Ming-Kuei Jang; Hui-Chen Lu; Robia G Pautler
Journal:  Neuroimage Clin       Date:  2014-03-31       Impact factor: 4.881

Review 10.  Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.

Authors:  Steven A Harris; Elizabeth A Harris
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.